ANDA Same-Day Filers Should Share Exclusivity, Industry Lawyer Says

FDA should allow ANDA applicants who file the first Paragraph IV certifications against a patent on the same day to share 180-day exclusivity, industry attorney David Adams said at a Food & Drug Law Institute conference in Washington, D.C. April 2